Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IL-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | IL-1 |
| Key Genes/Proteins | NLRP3, NF-κB, IL-17, NF-KB |
| Related Diseases | Cognitive Impairment, Mitochondrial dysfunction-associated senescence, Atherosclerosis, Inflammatory Senescence-Associated Secretory Phenotype, Senescence-associated secretory phenotype |
Knowledge base pages for this entity
graph TD
IL_1["IL-1"]
style IL_1 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
IL_1 -->|"contributes to"| Atherosclerosis["Atherosclerosis"]
IL_1 -->|"mediates"| Inflammatory_Senescence_Associ(Inflammatory Senescence-Associated Secretory Phenotype)
IL_1 -->|"activates"| Ms["Ms"]
IL_1 -->|"activates"| Tumor["Tumor"]
IL_1 -->|"activates"| Inflammation["Inflammation"]
IL_1 -->|"activates"| Alzheimer["Alzheimer"]
IL_1 -->|"activates"| Aging["Aging"]
IL_1 -->|"activates"| Phagocytosis["Phagocytosis"]
IL_1 -->|"activates"| OCLN([OCLN])
IL_1 -->|"activates"| MLCK([MLCK])
NLRP3([NLRP3]) -->|"activates"| IL_1
IL_17([IL-17]) -->|"co_expressed_with"| IL_1
DISEASE_ASSOCIATED_MICROGLIA([DISEASE-ASSOCIATED MICROGLIA]) -->|"activates"| IL_1
TNFR1([TNFR1]) -->|"activates"| IL_1
AND([AND]) -->|"activates"| IL_1
MICROGLIA([MICROGLIA]) -->|"activates"| IL_1
MYELIN([MYELIN]) -->|"activates"| IL_1
CYTOKINES([CYTOKINES]) -->|"activates"| IL_1
NEURODEGENERATIVE_DISEASES([NEURODEGENERATIVE DISEASES]) -->|"activates"| IL_1
PHAGOCYTOSIS([PHAGOCYTOSIS]) -->|"activates"| IL_1| Target | Relation | Type | Str |
|---|---|---|---|
| Cognitive Impairment | associated_with | phenotype | 0.85 |
| Systemic Inflammation | mediates | process | 0.85 |
| Atherosclerosis | contributes_to | disease | 0.80 |
| Inflammatory Senescence-Associated Secretory Phenotype | mediates | phenotype | 0.80 |
| MICROGLIA | upregulates | cell_type | 0.80 |
| Senescence-associated secretory phenotype | regulates | phenotype | 0.80 |
| Ms | activates | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Senescence | activates | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.65 |
| Autoimmune | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Inflammation | interacts_with | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Ferroptosis | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Neuroinflammation | inhibits | disease | 0.65 |
| Ischemia | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Stroke | therapeutic_target | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Pyroptosis | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Neuroinflammation | associated_with | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Ferroptosis | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Dementia | activates | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| Als | contributes_to | disease | 0.65 |
| Dementia | contributes_to | disease | 0.65 |
| Neurodegeneration | contributes_to | disease | 0.65 |
| Neuroinflammation | contributes_to | disease | 0.65 |
| Stroke | inhibits | disease | 0.65 |
| Pyroptosis | inhibits | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NLRP3 | activates | protein | 0.90 |
| NF-κB | upregulates | protein | 0.85 |
| Mitochondrial dysfunction-associated senescence | inhibits | phenotype | 0.85 |
| IL-17 | co_expressed_with | protein | 0.80 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.74 |
| NF-KB | associated_with | protein | 0.66 |
| ALS | associated_with | disease | 0.66 |
| DISEASE-ASSOCIATED MICROGLIA | activates | gene | 0.60 |
| TNFR1 | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| IL-10 | associated_with | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| MYELIN | activates | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.60 |
| PHAGOCYTOSIS | activates | gene | 0.60 |
| IL-10 | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| ALZHEIMER'S DISEASE | activates | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| NAD | associated_with | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | associated_with | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| ALPK1 | activates | gene | 0.60 |
| TRAF2 | activates | gene | 0.60 |
| LAMP1 | associated_with | gene | 0.60 |
| PPAR | activates | gene | 0.60 |
| CLDN1 | activates | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| INFLAMMATION | interacts_with | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | activates | gene | 0.60 |
| C1Q | activates | gene | 0.60 |
| PSME3 | therapeutic_target | gene | 0.60 |
| BAD | therapeutic_target | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| LAMP2 | therapeutic_target | gene | 0.60 |
| BID | therapeutic_target | gene | 0.60 |
| TLR2 | associated_with | gene | 0.60 |
| AUTOPHAGY | therapeutic_target | gene | 0.60 |
| SPR | inhibits | gene | 0.60 |
| PFKFB3 | inhibits | gene | 0.60 |
| LDHA | inhibits | gene | 0.60 |
| HK2 | inhibits | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| STROKE | therapeutic_target | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| NRF2 | activates | gene | 0.60 |
| STROKE | activates | gene | 0.60 |
| CX3CR1 | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| IL-10-Producing B10 Cells Establish AQP4-Specific Peripheral | 0.601 | neuroinflammation | How do B cells mechanistically orchestra |
| TNF-α/IL-1β-Cx43 Hemichannel Axis as Upstream Link Between S | 0.548 | cell biology | What is the relative contribution of con |
| TYRO3-STAT1 Axis to Preserve Parvalbumin Interneuron Functio | 0.499 | neuroinflammation | Why do TAM receptors protect against neu |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.521
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||